Home Tags RED-106

Tag: RED-106

Catalent’s SMARTag® ADC Stands Out in the Crowd of HER2-targeted Conjugates

The steadily growing number of HER2-targeted antibody-drug conjugates (ADCs) in preclinical development is a testament to the success of the original anti-HER2 ADC, ado-trastuzumab...